Royal Bank Of Canada Reiterates “Sector Perform” Rating for Marlowe (LON:MRL)

Marlowe (LON:MRLGet Free Report)‘s stock had its “sector perform” rating reissued by investment analysts at Royal Bank Of Canada in a report released on Wednesday, Marketbeat.com reports. They presently have a GBX 466 ($6.26) price objective on the stock. Royal Bank Of Canada’s price target indicates a potential upside of 5.91% from the stock’s previous close.

Marlowe Stock Up 0.5%

Shares of Marlowe stock opened at GBX 440 ($5.91) on Wednesday. The stock has a market capitalization of £352.09 million, a P/E ratio of -40.92 and a beta of 0.44. The company has a quick ratio of 0.80, a current ratio of 1.24 and a debt-to-equity ratio of 58.99. The stock has a 50 day moving average price of GBX 412.73 and a two-hundred day moving average price of GBX 357.67. Marlowe has a 12-month low of GBX 220 ($2.95) and a 12-month high of GBX 490 ($6.58).

Marlowe (LON:MRLGet Free Report) last posted its quarterly earnings data on Thursday, June 26th. The company reported GBX 15.30 ($0.21) earnings per share for the quarter. Marlowe had a negative return on equity of 2.33% and a negative net margin of 2.03%. Equities analysts expect that Marlowe will post 12.4863487 earnings per share for the current year.

About Marlowe

(Get Free Report)

Marlowe is a leader in business-critical services and software which assure regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services – all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation.

Recommended Stories

Receive News & Ratings for Marlowe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marlowe and related companies with MarketBeat.com's FREE daily email newsletter.